COVID-19

White Papers

COVID-19’s lasting impact on digital communication in health...

The ongoing digital transformation of the healthcare and pharmaceutical industries has been greatly accelerated during the coronavirus pandemic.

News

Moderna’s COVID vaccine works in older people, according to ...

Moderna has said that its coronavirus vaccine stimulated an immune response in older people in phase 1 trials, suggesting that the jab is effective in the age groups most susceptible to COVID-19

R&D

Close up of examining of test sample under the microscope in laboratory.

COVID-19 is causing a renaissance in the UK biotech sector, ...

Despite the UK’s world class research output and the many start-ups successfully spinning out from its academic institutions, in recent years UK biotech companies have struggled to access t

R&D

Alnylam, gene-silencing and biotech in 2020: the pharmaphoru...

Alnylam's Brendan Martin joined the pharmaphorum podcast for episode 23 to talk about his company's work in gene-silencing and how it could offer a route to target the current coronavirus p

Views & Analysis

3d illustration and concept of international logistics of agreements and international business. Networks and companies around the world

Time for a health innovation pact: rethinking the design and...

Janssen’s Anouk De Vroey on why we need to extend the public/private partnerships resulting from COVID-19 into more high-level dialogue on health innovation with governments.

News

Chasing Regeneron, AZ starts trials of its COVID-19 antibody...

The first patients have been dosed in a trial of two AstraZeneca antibodies, collectively known as AZD7442, that are being developed to both treat and prevent coronavirus infec